Single-Use Ureteroscopes Market Size, Share, Growth, and Industry Analysis, By Type (Digital Ureteroscopes,Fiberoptic Ureteroscopes), By Application (Hospitals,Clinics,Ambulatory Surgical Centers), Regional Insights and Forecast to 2035

Unique Information about the Single-Use Ureteroscopes Market

Global Single-Use Ureteroscopes market size is anticipated to be valued at USD 251.04 million in 2026, with a projected growth to USD 382.16 million by 2035 at a CAGR of 4.8%.

The Single-Use Ureteroscopes Market is characterized by increasing procedural volumes, with over 2.5 million ureteroscopy procedures performed globally each year, of which approximately 35% involve disposable devices. Single-use ureteroscopes reduce cross-contamination risks by nearly 90% compared to reusable scopes. Hospitals report sterilization cost reductions of up to 45% per procedure when switching to disposable systems. Around 60% of healthcare facilities in developed regions have adopted single-use devices in at least one department. Device failure rates in reusable ureteroscopes range between 12% and 18%, whereas single-use variants demonstrate failure rates below 5%, improving clinical efficiency and turnaround time by approximately 25%.

In the United States, over 1.2 million kidney stone cases are treated annually, with ureteroscopy used in nearly 70% of cases. Approximately 55% of urologists in the U.S. now prefer single-use ureteroscopes for infection-sensitive procedures. Healthcare-associated infections linked to reusable endoscopes account for nearly 15% of reported cases, pushing adoption of disposable alternatives. Around 65% of ambulatory surgical centers in the U.S. have integrated single-use ureteroscopes into their workflows. The FDA has cleared more than 25 disposable ureteroscope models since 2015, and usage rates have increased by over 40% between 2020 and 2024.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Over 78% report infection reduction, 64% note 50% fewer sterilization issues, and 72% see improved procedural efficiency.
• Major Market Restraint: About 58% cite high costs, 47% face budget limits, 36% worry about waste, and 29% report procurement challenges.
• Emerging Trends: Nearly 69% focus on digital imaging, 52% use AI, 61% improve ergonomics, while 55% prioritize better resolution features.
• Regional Leadership: North America leads with 42%, Europe holds 28%, Asia-Pacific 22%, and others 8%, with adoption rising over 35% annually.
• Competitive Landscape: Top 5 players hold 68%, mid-tier 22%, startups 10%, with innovation activity increasing by 45% in recent years.
• Market Segmentation: Digital devices lead with 63%, fiberoptic 37%, hospitals use 54%, clinics 28%, and ambulatory centers account for 18%.
• Recent Development: Around 35% launches improve imaging, 42% optimize design, 33% enhance durability, and 27% integrate wireless connectivity features.

Single-Use Ureteroscopes Market Latest Trends

The Single-Use Ureteroscopes Market Trends reflect a strong technological transformation, with nearly 65% of newly launched devices integrating high-definition imaging above 1080p, significantly improving visualization accuracy. Around 58% of manufacturers are investing in CMOS sensor technologies, enhancing image clarity by up to 30%. Flexible ureteroscopes with deflection capabilities exceeding 270 degrees account for approximately 62% of demand, supporting complex procedures. Disposable devices have reduced average procedure times by 20%, while outpatient procedures now represent nearly 48% of total cases. About 55% of urologists prefer single-use scopes due to consistent performance, especially compared to reusable devices that degrade after 15–20 uses.

The Single-Use Ureteroscopes Market Growth is further driven by rising urolithiasis prevalence affecting 12% of the population, with 70% of cases requiring ureteroscopy. However, challenges persist, as disposable devices are 25% to 40% more expensive, with 45% of providers citing cost constraints. Opportunities are expanding with ambulatory surgical centers growing by 35% and performing 40% of procedures. Environmental concerns remain critical, as medical waste increases by 15% annually, while only 18% of devices are recycled, and regulatory requirements impact 30% of market dynamics.

Single-Use Ureteroscopes Market Dynamics

DRIVER

"Rising prevalence of urological disorders and kidney stones"

The Single-Use Ureteroscopes Market Growth is significantly driven by the increasing prevalence of urological disorders, with urolithiasis affecting nearly 12% of the global population and recurrence rates reaching up to 50% within 5 years. Approximately 70% of kidney stone cases require ureteroscopy, directly increasing demand for advanced devices. Hospitals have reported a 30% rise in minimally invasive procedures over the past decade, reflecting a strong shift toward endoscopic treatments. High-volume healthcare centers performing over 500 procedures annually increasingly rely on disposable ureteroscopes due to their efficiency. Infection risks are reduced by nearly 90%, improving patient outcomes, while procedural turnaround times improve by approximately 25%, further supporting adoption across large healthcare systems.

RESTRAINT

"High per-procedure cost of disposable devices"

The Single-Use Ureteroscopes Market Challenges are influenced by higher per-procedure costs, as disposable devices are 25% to 40% more expensive compared to reusable alternatives in high-volume hospitals. Around 45% of healthcare providers report budget constraints limiting widespread adoption, particularly in cost-sensitive regions. Waste management expenses have increased by approximately 18% due to growing use of disposable medical devices. Additionally, 32% of healthcare facilities cite reimbursement limitations as a significant barrier, especially in emerging economies where healthcare expenditure per capita remains below $1,000 annually. Nearly 40% of procurement managers prioritize cost-efficiency, leading to selective adoption strategies and slower penetration of single-use ureteroscopes in mid-sized and resource-limited healthcare institutions.

OPPORTUNITY

"Expansion in ambulatory surgical centers and emerging markets"

The Single-Use Ureteroscopes Market Opportunities are expanding due to the rapid growth of ambulatory surgical centers, which have increased by 35% globally and now perform approximately 40% of urological procedures. These centers favor disposable devices due to the absence of complex sterilization infrastructure, improving operational efficiency by nearly 30%. Emerging markets such as India and China account for over 45% of untreated urological cases, presenting strong demand potential. Government healthcare investments have increased by 20% across Asia-Pacific, supporting procurement of advanced medical devices. Portable ureteroscopes with battery-powered systems have gained 28% traction, particularly in rural and remote healthcare facilities, while nearly 50% of private hospitals in developing regions are shifting toward single-use technologies

CHALLENGE

"Environmental impact and regulatory concerns"

The Single-Use Ureteroscopes Market Outlook faces challenges related to environmental sustainability, as medical waste generated from disposable devices is increasing by approximately 15% annually. Around 52% of healthcare providers express concerns regarding long-term environmental impact and waste management practices. Regulatory compliance requirements have risen by nearly 30%, particularly in Europe, where strict environmental and safety standards influence procurement decisions. Recycling initiatives currently cover only 18% of disposable medical devices, highlighting gaps in sustainability infrastructure. Additionally, approximately 25% of manufacturers experience delays in regulatory approvals, which can extend product launch timelines by 6 to 12 months. These factors collectively impact market expansion and create operational complexities for manufacturers and healthcare providers.

Segmentation Analysis

The Single-Use Ureteroscopes Market Size is segmented by type and application, with digital devices accounting for 63% and fiberoptic devices 37%. Hospitals dominate applications with 54%, followed by clinics at 28% and ambulatory surgical centers at 18%. Increasing procedural volumes exceeding 2 million annually drive segmentation growth, while technology advancements improve adoption rates by 35%.

Download FREE Sample to learn more about this report.

By Type

Digital Ureteroscopes: Digital ureteroscopes hold approximately 63% market share due to superior imaging quality, offering resolutions above 1080p in 70% of devices. Nearly 60% of hospitals prefer digital scopes for complex procedures requiring precise visualization. These devices reduce diagnostic errors by 25% and improve procedural success rates by 30%. Over 50% of manufacturers are focusing on digital innovations, and adoption rates have increased by 45% over the past 5 years. Enhanced durability ensures consistent performance across 100% of procedures, eliminating variability.

Fiberoptic Ureteroscopes: Fiberoptic ureteroscopes account for 37% market share, primarily due to lower cost and accessibility. Approximately 48% of clinics still use fiberoptic devices for basic procedures. These scopes offer flexibility of up to 270 degrees and are preferred in 35% of outpatient procedures. However, image clarity is 20% lower compared to digital devices. Fiberoptic models are used in over 40% of developing regions where budget constraints limit adoption of advanced systems.

By Application

Hospitals: Hospitals dominate the Single-Use Ureteroscopes Market Share with 54%, conducting more than 1.5 million procedures annually across high-volume healthcare systems. Around 65% of large hospitals have integrated disposable ureteroscopes into at least one department, particularly in urology units handling over 300 procedures per month. Infection control protocols have improved by nearly 40%, significantly reducing cross-contamination risks. Operational efficiency has increased by approximately 25%, as single-use devices eliminate sterilization delays. Additionally, nearly 60% of hospitals report improved workflow consistency, while 55% prioritize disposable devices for complex and high-risk urological procedures.

Clinics: Clinics contribute 28% to the Single-Use Ureteroscopes Market Size, with nearly 45% of outpatient urological procedures performed in these settings. Disposable ureteroscopes reduce preparation and setup time by approximately 30%, enabling clinics to manage up to 20% more patients daily. Around 50% of clinics prefer single-use devices due to limited sterilization facilities and reduced maintenance requirements. Adoption rates have increased by 35% over the past 3 years, driven by cost efficiency and workflow optimization. Additionally, about 40% of clinics report improved patient throughput and shorter waiting times with disposable technologies.

Ambulatory Surgical Centers: Ambulatory surgical centers hold 18% of the Single-Use Ureteroscopes Market Share, with procedure volumes growing by over 30% annually. Approximately 60% of these centers rely exclusively on single-use devices due to their operational simplicity and efficiency. Procedure turnaround times have improved by nearly 40%, allowing faster patient flow and increased scheduling capacity. More than 85% of patients are discharged within 24 hours, highlighting efficiency in care delivery. Sterilization cost savings reach up to 50%, while nearly 55% of centers report improved resource utilization and reduced equipment downtime with disposable ureteroscopes.

Regional Outlook

The Single-Use Ureteroscopes Market Outlook shows North America leading with 42% share, followed by Europe at 28%, Asia-Pacific at 22%, and Middle East & Africa at 8%. Over 2.5 million procedures globally drive demand, while adoption rates exceed 60% in developed regions. Emerging markets contribute nearly 50% of unmet needs, with healthcare investments increasing by 20% across Asia-Pacific and Africa.

Download FREE Sample to learn more about this report.

North America

North America dominates the Single-Use Ureteroscopes Market Share with approximately 42%, supported by more than 1.5 million urological procedures conducted annually across the region. The United States contributes nearly 80% of total regional demand, reflecting a highly developed healthcare infrastructure and widespread access to advanced medical technologies. Around 70% of hospitals in North America have adopted single-use ureteroscopes, driven by strong infection control protocols and clinical efficiency requirements. Healthcare expenditure per capita exceeds $10,000, enabling rapid integration of innovative disposable devices into surgical workflows.

Infection rates associated with reusable endoscopes have declined by approximately 35% following the adoption of single-use alternatives, significantly improving patient safety outcomes. Over 60% of ambulatory surgical centers utilize disposable ureteroscopes, benefiting from reduced sterilization costs and faster procedure turnaround times of up to 25%. Regulatory approvals for new devices have increased by 25% since 2020, indicating strong support for technological advancement. Additionally, more than 50% of healthcare providers prioritize single-use devices for high-risk procedures, while digital ureteroscopes account for nearly 65% of usage in advanced healthcare facilities across the region.

Europe

Europe represents approximately 28% of the Single-Use Ureteroscopes Market Size, with over 900,000 ureteroscopy procedures performed annually. Germany, France, and the United Kingdom collectively contribute around 65% of regional demand, highlighting concentration in developed healthcare systems. Approximately 55% of hospitals across Europe have adopted single-use ureteroscopes, primarily driven by strict infection prevention regulations and quality assurance standards. Adoption rates have increased by nearly 40% due to enhanced compliance requirements and clinical safety initiatives.

Medical waste management policies influence approximately 30% of procurement decisions, as sustainability considerations become increasingly important in healthcare operations. Digital ureteroscopes account for about 60% of total usage in Western Europe, reflecting higher investment in advanced imaging technologies. In contrast, Eastern Europe demonstrates adoption rates of around 35%, indicating gradual market penetration. Healthcare spending per capita in Western Europe ranges between $4,000 and $6,000, supporting device accessibility. Additionally, over 45% of healthcare facilities report improved procedural efficiency of up to 20% with disposable devices, while nearly 50% prioritize infection control measures when selecting ureteroscopic equipment.

Asia-Pacific

Asia-Pacific holds approximately 22% of the Single-Use Ureteroscopes Market Growth, with more than 1 million untreated urological cases reported annually, indicating significant unmet medical demand. China and India together account for nearly 55% of regional demand, driven by large population bases and increasing prevalence of kidney stone diseases affecting approximately 10% to 12% of adults. Adoption rates in urban hospitals have increased by 45%, supported by rapid healthcare modernization and infrastructure development.

Government healthcare spending has risen by approximately 20%, enabling procurement of advanced disposable medical devices and improving access to minimally invasive procedures. Around 50% of private hospitals in the region prefer single-use ureteroscopes due to limited sterilization infrastructure and the need for cost-efficient operations. Rural healthcare facilities currently show adoption rates of about 25%, indicating growth potential in underserved areas. Portable ureteroscope devices have increased procedural accessibility by 30%, particularly in remote locations. Additionally, nearly 40% of new healthcare investments are directed toward improving diagnostic technologies, while digital ureteroscopes account for approximately 55% of usage in leading urban medical centers.

Middle East & Africa

The Middle East & Africa region accounts for approximately 8% of the Single-Use Ureteroscopes Market Outlook, with adoption rates increasing by around 35% annually. Approximately 40% of tertiary care hospitals have implemented single-use ureteroscopes, primarily in urban healthcare facilities with advanced infrastructure. Healthcare investments in the region have grown by 25%, focusing on improving surgical capabilities and expanding access to minimally invasive procedures.

Infection control awareness has increased by 30%, driving demand for disposable devices that eliminate cross-contamination risks. Gulf Cooperation Council countries contribute nearly 60% of regional usage, supported by higher healthcare spending per capita exceeding $2,000 in some areas. In Africa, adoption rates remain lower, with approximately 20% of urban hospitals utilizing single-use ureteroscopes, highlighting opportunities for market expansion. Portable and battery-operated devices have improved procedural access by 28%, particularly in remote and resource-limited settings. Additionally, around 35% of healthcare providers in the region are prioritizing modern diagnostic tools, while partnerships with international manufacturers have increased by 20%, facilitating technology transfer and improving device availability.

List of Top Single-Use Ureteroscopes Companies

• Olympus Corporation – holds approximately 28% market share with over 50 product variants and presence in 70+ countries
• Boston Scientific Corporation – accounts for nearly 22% market share with over 40% adoption in U.S. hospitals

Investment Analysis and Opportunities

The Single-Use Ureteroscopes Market Opportunities are witnessing significant expansion, supported by a 35% increase in overall investments between 2021 and 2025. Venture capital activity has grown by 28%, with more than 60% of funding directed toward disposable endoscopy technologies, reflecting strong investor confidence in infection-control-driven solutions. Around 45% of manufacturers are actively allocating budgets toward research and development, particularly focusing on imaging quality improvements and enhanced device flexibility. Healthcare facilities have increased their allocation toward infection prevention technologies by approximately 30%, aligning with rising regulatory standards and patient safety priorities.

Emerging markets account for over 50% of unmet clinical demand, particularly in Asia-Pacific and Africa, where healthcare access remains limited. Government healthcare funding has increased by 20%, enabling procurement of advanced disposable devices. Strategic collaborations between hospitals and manufacturers have risen by 25%, facilitating bulk purchasing and cost optimization. Investment in AI-integrated ureteroscopes has grown by 32%, resulting in a 27% improvement in diagnostic precision. Additionally, nearly 40% of new investments are directed toward portable and wireless systems, which are critical for expanding urological care into remote and underserved regions.

New Product Development

New product development in the Single-Use Ureteroscopes Market Trends is increasingly centered on technological innovation, with approximately 65% of devices launched between 2023 and 2025 featuring high-definition imaging systems exceeding standard visualization benchmarks. Flexible ureteroscopes with deflection capabilities above 275 degrees have increased by 30%, enabling better navigation in complex anatomical structures. Lightweight device designs under 250 grams have improved surgeon handling efficiency by 35%, reducing fatigue during longer procedures.

Wireless connectivity features have expanded by 38%, allowing seamless real-time data transmission and integration with hospital imaging systems. Around 50% of manufacturers are incorporating artificial intelligence-based imaging technologies, which enhance stone detection accuracy by approximately 28%. Battery-operated portable devices now represent 25% of new product introductions, supporting mobility and use in decentralized healthcare settings. Improved irrigation systems delivering flow rates above 100 ml/min have enhanced visibility and reduced procedure time by 20%. Additionally, durability enhancements ensure consistent single-use performance across 100% of procedures, lowering device-related complications by 18% and increasing clinical reliability.

Five Recent Developments (2023-2025)

• In 2023, over 40% of new ureteroscope launches included HD imaging above 1080p resolution.
• In 2024, approximately 35% of devices integrated AI-assisted visualization features.
• In 2025, flexible ureteroscopes with 275-degree deflection increased by 30% in product portfolios.
• Between 2023 and 2024, wireless-enabled ureteroscopes adoption grew by 38%.
• In 2025, lightweight devices under 250 grams accounted for 45% of new product introductions.

Report Coverage of Single-Use Ureteroscopes Market

The Single-Use Ureteroscopes Market Report delivers a comprehensive evaluation of industry performance across 4 key regions and more than 20 countries, incorporating data from over 2 million ureteroscopy procedures conducted annually. It examines more than 50 product types and profiles over 30 manufacturers, providing a detailed overview of technological penetration and adoption rates. The report highlights that digital ureteroscopes account for 63% of total usage, while hospitals contribute 54% of application share, reflecting strong demand in high-volume healthcare settings. Infection reduction rates of up to 90% are documented, demonstrating the clinical advantages of disposable devices compared to reusable alternatives.

The Single-Use Ureteroscopes Industry Analysis further identifies operational efficiency improvements of approximately 25%, driven by reduced sterilization requirements and faster procedure turnaround times. Regulatory frameworks influence nearly 30% of market dynamics, particularly in regions with strict infection control standards. Investment activity shows an increase of over 35% in funding allocation toward research, innovation, and device development. Technological advancements such as AI integration and wireless connectivity are incorporated in nearly 40% of new product designs, enhancing diagnostic accuracy and usability. The report includes over 100 quantitative data points, enabling stakeholders to make informed decisions across procurement, manufacturing, and distribution channels.